Malgorzata Sztolsztener

Director, Clinical Trial Transparency Patient Engagement at AstraZeneca

Speaker

Malgorzata Sztolsztener is the Director of Clinical Trial Transparency Patient Engagement for AstraZeneca. She has been with AstraZeneca for 9 years now, initially she specialized in clinical trial disclosure activities including registration and technical results submissions. Since 2018 she leads the delivery of Trial Results Summaries and other patient communications written in an easy-to-understand language to participants of AstraZeneca clinical trials globally. As part of her role Malgorzata is involved in several industry working groups contributing to CTT standards and best practices. Prior to joining AstraZeneca, Malgorzata worked at the postdoctoral position as a biochemist in one of the top research centers in Poland.